Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 12, 2026 · Filed Nov 13, 2026
A Larimar Therapeutics director paid $187K out of pocket for Larimar Therapeutics shares. 6 other people at Larimar Therapeutics bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Written by software from the filings listed below · Nov 13, 2026
5 more points, with the facts they come from, are in OQRO Pro.
Sign up freeopen market purchase
Code P — open-market or private purchase
~$187,082
Shares × reported transaction price
$100K–$500K
First purchase in 4 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 2 earlier confirmed purchases
7 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
3 days after results of Nov 9, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $2.70 on Nov 12, 2026, 36% above its 52-week low and 55% below its high, after a 12% drop over the previous 30 trading days
52-week range $1.99 (Oct 16, 2026) to $5.95 (Feb 25, 2026), 18% of the way up, from 250 adjusted closes. 30 trading days earlier: $3.06 on Oct 1, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
7 LRMR insiders bought within the same week; no week in filings since 2014 had that many buyers
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider buying
6 insiders in a week, a first since 2014Traded Nov 11 · filed 1 day later
Larimar Therapeutics's Chief Development Officer paid $14K out of pocket for Larimar Therapeutics shares. 6 other people at Larimar Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Insider buying
6 insiders in a week, a first since 2014Traded Nov 11 · filed 1 day later
The CFO of Larimar Therapeutics paid $50K out of pocket for Larimar Therapeutics shares. 6 other people at Larimar Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Insider buying
6 insiders in a week, a first since 2014Traded Nov 11 · filed 1 day later
A Larimar Therapeutics director paid $9.8K out of pocket for Larimar Therapeutics shares. 6 other people at Larimar Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.